Researchers at UT Arlington have discovered a key enzyme, IDO1, that when blocked, helps immune cells regain their ability to properly process cholesterol—something that breaks down during ...

Heart disease is the leading cause of death around the world. However, overall heart disease death rates over the past five ...

Millions more Americans should be taking weight-loss drugs to prevent heart disease, according to the American College of ...

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

Results from a clinical trial of a novel aldosterone synthase inhibitor, lorundrostat, found it significantly reduces ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...

Due to the study's results on cannabis use health risks, an editorial note published alongside the research called for the ...

Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items ...

A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction ...

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has recently completed a clinical study titled A ...

As per reports, the legal battle between Novartis and MSN is expected to move to the next patent, which expires in November ...

Marijuana users are up to twice as likely to have a stroke, heart attack, or die from heart disease, research has revealed.